USPTO serial 77250843
SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 23, 2008
- Examiner
- COWARD, JEFFERY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Reckitt Benckiser Healthcare (UK) Limited
Hull, GB
Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
Reckitt Benckiser Healthcare (UK) Limited
Hull, GB
Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
Reckitt Benckiser Healthcare (UK) Limited
Hull, GB
Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
SLOUGH, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark Lerner
Mark Lerner Satterlee Stephens Burke & Burke LLP230 Park AvenueSuite 1130New York, NY 10169-0079Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 044 | Provision of healthcare advice; providing information relating to opioid dependence | SECTION 8 - CANCELLED | Sep 1, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
- Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
- Other trademarks owned by Reckitt Benckiser Healthcare (UK) Limited
- Other trademarks owned by RB PHARMACEUTICALS LIMITED
- Other trademarks in Class 044
- Similar marks named SUBOXONE (BUPRENORPHINE HCI/NALOXONE HCI DIHYDRATE) SUBLINGUAL TABLETS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 20, 2024 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Apr 24, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 31, 2014 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Feb 12, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Mar 8, 2010 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 8, 2010 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 23, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 18, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| May 30, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 30, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 29, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 29, 2008 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 29, 2008 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 29, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 28, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 28, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 28, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 30, 2007 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Nov 30, 2007 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2007 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Nov 29, 2007 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Nov 29, 2007 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Nov 16, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2007 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Aug 14, 2007 | NWAP | NEW APPLICATION ENTERED | — |